246 filings
Page 6 of 13
424B5
02g2cdv68s mk7fmmta0
1 Jul 20
Prospectus supplement for primary offering
5:12pm
424B5
hf66hzf7
29 Jun 20
Prospectus supplement for primary offering
4:24pm
8-K
uhrmgnuu5hh
12 Jun 20
Departure of Directors or Certain Officers
4:28pm
8-K
21vp4tc6s07q9 42w0
12 Jun 20
Regulation FD Disclosure
6:04am
DEFA14A
c11xig
15 May 20
Additional proxy soliciting materials
4:30pm
8-K
8j5vyhsrwacxxqui3
14 May 20
Regulation FD Disclosure
9:11am
8-K
fvmu45sce
11 May 20
Regulation FD Disclosure
9:12am
8-K
jsce 7ce6
28 Apr 20
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results
4:50pm
DEFA14A
pwjcms0q8a3 f3t4ah
24 Apr 20
Additional proxy soliciting materials
4:11pm
D/A
fecsmyeysc63bued6k
10 Apr 20
$1M in equity, sold $1M, 1 investor
11:01am
D
msvwevi0gy67m
9 Apr 20
$1M in equity, sold $1M, 1 investor
4:42pm
8-K
dnmvm8nv
31 Mar 20
Other Events
4:08pm
8-K
3ja6tgf
26 Feb 20
CRISPR Therapeutics Proposes Changes to the Board of Directors
4:10pm
8-K
9fb9typ4
12 Feb 20
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:05pm
8-K
ffanlxu1onqgrri7
29 Jan 20
Departure of Directors or Certain Officers
4:16pm
8-K
tra93v4 hyvq85v8uvwi
27 Dec 19
Termination of a Material Definitive Agreement
4:06pm